Tilray Brands (TLRY) Expected to Announce Quarterly Earnings on Wednesday

Tilray Brands (NASDAQ:TLRY) is anticipated to release its Q3 2026 results before the market opens on Wednesday, April 1st. Analysts expect the company to announce earnings of ($0.14) per share and revenue of $201.35 million for the quarter. Parties can find conference call details on the company’s upcoming Q3 2026 earning report page for the latest details on the call scheduled for Tuesday, April 7, 2026 at 8:30 AM ET.

Tilray Brands (NASDAQ:TLRY) last posted its quarterly earnings data on Thursday, January 8th. The company reported ($0.02) EPS for the quarter, topping the consensus estimate of ($0.14) by $0.12. Tilray Brands had a negative net margin of 251.69% and a negative return on equity of 6.35%. The business had revenue of $217.51 million during the quarter, compared to the consensus estimate of $211.15 million. During the same period in the previous year, the firm posted ($0.03) earnings per share. On average, analysts expect Tilray Brands to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Tilray Brands Price Performance

NASDAQ TLRY opened at $6.32 on Monday. The company has a market cap of $736.32 million, a price-to-earnings ratio of -0.29 and a beta of 1.96. The company has a debt-to-equity ratio of 0.19, a current ratio of 2.81 and a quick ratio of 1.72. The stock’s fifty day moving average price is $7.53 and its 200 day moving average price is $10.35. Tilray Brands has a 1 year low of $3.51 and a 1 year high of $23.20.

Trending Headlines about Tilray Brands

Here are the key news stories impacting Tilray Brands this week:

• Positive Sentiment: Tilray announced a branded ready‑to‑drink (RTD) licensing deal to launch Popsicle® “Popsicle Adult Beverages” — a line of 5% ABV RTD flavors (Hard Cherry, Hard Orange, Hard Grape) aimed at 21+ consumers in the U.S. The tie-up leverages a well-known legacy brand, expands Tilray’s beverage portfolio and could add higher‑margin CPG revenue streams if distribution and consumer trial scale. Article Title Article Title
• Neutral Sentiment: Product and commercial execution remain the key unknowns — timing, distribution partners, marketing spend and consumer acceptance will determine materiality to revenue. The announcement signals product diversification but does not yet provide launch timing, shelf distribution or forecasted incremental revenue. Article Title
• Negative Sentiment: Despite the licensing news, the stock traded down in recent sessions and has seen negative headlines about a decline in the latest close — indicating profit-taking or rotation by investors who may view the licensing deal as incremental rather than immediately transformative. Short-term sentiment appears weak, which can pressure the share price until clearer commercial milestones or sales results emerge. Article Title Article Title

Analyst Upgrades and Downgrades

TLRY has been the topic of several research analyst reports. Wall Street Zen upgraded Tilray Brands from a “sell” rating to a “hold” rating in a research note on Saturday, March 21st. Roth Mkm reduced their price objective on Tilray Brands from $20.00 to $10.00 and set a “neutral” rating for the company in a research note on Tuesday, January 20th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Tilray Brands in a report on Wednesday, January 21st. ATB Cormark Capital Markets upgraded shares of Tilray Brands from a “strong sell” rating to a “hold” rating in a report on Wednesday, December 10th. Finally, Canaccord Genuity Group started coverage on shares of Tilray Brands in a research note on Tuesday, January 27th. They set a “hold” rating for the company. One research analyst has rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Tilray Brands presently has a consensus rating of “Hold” and an average target price of $13.33.

Hedge Funds Weigh In On Tilray Brands

Several institutional investors and hedge funds have recently modified their holdings of the stock. AQR Capital Management LLC boosted its stake in shares of Tilray Brands by 1,839.7% in the first quarter. AQR Capital Management LLC now owns 607,054 shares of the company’s stock worth $399,000 after buying an additional 575,757 shares during the last quarter. XTX Topco Ltd acquired a new position in Tilray Brands in the second quarter valued at approximately $112,000. Cerity Partners LLC boosted its position in Tilray Brands by 98.5% in the 2nd quarter. Cerity Partners LLC now owns 92,560 shares of the company’s stock worth $38,000 after purchasing an additional 45,929 shares in the last quarter. Ausdal Financial Partners Inc. purchased a new stake in Tilray Brands in the 2nd quarter worth approximately $939,000. Finally, Bank of America Corp DE grew its stake in shares of Tilray Brands by 26.5% during the 2nd quarter. Bank of America Corp DE now owns 311,810 shares of the company’s stock worth $129,000 after purchasing an additional 65,379 shares during the period. Institutional investors and hedge funds own 9.35% of the company’s stock.

Tilray Brands Company Profile

Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.

Tilray’s product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.